Global Wellness Strategies and KaleidoMyco Introduce One-Shot Drink Combining Functional Mushrooms with Hemp Extract

The one-shot utilizes proprietary extraction technologies for a refreshing on-the-go beverage

Global Wellness Strategies Inc. (CSE: LOAN) (FSE: O3X) (OTCQB: PNNRD) ("GWS" or the "Company") (formerly Redfund Capital Corp.) and KaleidoMyco, one of the first companies combining hemp extract and adaptogens, introduces its flavored antioxidant one-shot beverage combining functional mushrooms with hemp extract.

KaleidoMyco is combining 50 milligrams of hemp extract with functional mushrooms to launch a new one-shot wellness beverage utilizing its proprietary extraction techniques. KaleidoMyco will launch a blend of functional mushrooms in three likeable flavors including lemon lime, orange citrus, and grape.

The concept of a wellness shot designed for health benefits is not novel but in recent years they have gained traction at vitamin shops, fresh-pressed juice bars, and grocery stores. The 60-100oz tiny drinks often promise immune boosts and weight loss. Consumers flock to them and many of the most popular wellness shots on the market are now plant-based extraction products like KaleidoMyco's new hemp-myco shot.

In recent years functional edible mushrooms have attracted attention as a commercial source of antioxidants. Various anti-inflammatory compounds and substances in functional mushrooms offer relief from arthritis, muscle strain, and other common inflammatory conditions. It has been said that these mushrooms help stabilize the immune system and that they boost the body's defenses and even the production output of white blood cells1.

"The team at KaleidoMyco are innovators, mycologists and formulists, who look to introduce new wellness products that help consumers take care of themselves first. It is a boost to our minds and bodies not a cure is their philosophy and a theory that resonates during COVID 19. Bringing revenues to the bottom line in short order continues to be their fiscal mandate. We anticipate an online storefront and digital rollout on platforms such as Amazon shortly. A direct sales network plus distributors should be in full-swing by end of the next quarter," stated Meris Kott, CEO of Global Wellness Strategies Inc.

About KaleidoMyco

KaleidoMyco is one of the world's first companies combining hemp extract, adaptogens, and myco-based ingredients to produce world-class, data-driven, science-based wellness products. It is dedicated to driving ground-breaking innovations in the production and delivery of myco-derived formulations. KaleidoMyco has a team of experts who are actively working to lay the foundation in the psilocybin space as more developments in regulation become available.

About Global Wellness Strategies

Global Wellness Strategies is a prospect generator that provides high growth companies with financial, operational, and management assistance in the fast-growing market for wellness consumer products. The focus of the Company is on global wellness, hemp and CBD, healthcare-related target companies.

For further information, please visit our website:
www.globalwellnessstrategies.com or www.kaleidomyco.com

Contact
Meris Kott
CEO - 604.484.0355
info@globalwellnessstrategies.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain statements contained in this release may constitute "forward-looking statements" or "forward-looking information" (collectively "forward-looking information") as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated", "anticipates" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, its financing and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties, and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.


1 Kozarski M.S., Klaus A.S., Niksic M.P., van Griensven L.J.L.D., Vrvic M.M., Jakovljevic D.M. Polysaccharides of higher fungi: Biological role, structure and antioxidative activity. Chem. Ind. 2014;68:305-320. doi: 10.2298/HEMIND121114056K

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/81683.

News Provided by Newsfile via QuoteMedia

The Conversation (0)
Australia flag and cannabis.

Australian Senate Rejects Greens' Bill to Legalise Cannabis

The Australian Greens announced on Wednesday, November 27, that the Legalising Cannabis Bill 2023 was defeated in a 13 to 24 vote, preventing the federal legalisation of cannabis.

“The Labor and Coalition parties joined together to try and hold Australia back in the 1950s by blocking this desperately needed reform,” said Greens Senator for New South Wales David Shoebridge.

Shoebridge said on X that the parties “teamed up” to vote against legalizing cannabis in the Senate, “yet another example of the major parties working together to refuse any sort of progress.”

All 11 Greens Senators voted in favour of the Bill, as did Independent Senators Lidia Thorpe and Tammy Tyrrell.

Keep reading...Show less

Trulieve to Open Medical Cannabis Dispensary in Jacksonville, Florida

New Duval County location will host grand opening celebration Friday, December 6 th

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., announced the opening of a new medical cannabis dispensary in Jacksonville, Florida on Saturday, November 23 .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve Cannabis Corp. Announces Insider Share Purchases By Executive Leadership and Board Members

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced that several members of its executive management team and board of directors have recently made purchases of the company's subordinate voting shares, signaling their confidence in the company's growth potential and direction.

Trulieve logo (PRNewsfoto/Trulieve Cannabis Corp.)

Between November 8, 2024 and November 21, 2024 , Chairman and CEO Kim Rivers , Director Thad Beshears , Director Peter Healy , Director Richard May , Director Thomas Milner , Director Jane Morreau , Director Susan Thronson , Chief Marketing Officer Gina Collins , Chief Technology Officer Nilyum Jhala, Chief Production Officer Kyle Landrum , Chief Information Officer Jason Pernell , Chief Legal Officer Eric Powers , Chief Operating Officer Marie Zhang , and Vice President of Investor Relations Christine Hersey purchased a total of 72,273 shares at prices between $5.63 and $7.19 per share. These insider purchases reflect the confidence and commitment of leadership in the long-term strategic plan for Trulieve and its shareholders.

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com .

Facebook: @Trulieve
Instagram: @Trulieve _
X: @Trulieve

Investor Contact  
Christine Hersey , Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact  
Phil Buck , APR, Corporate Communications Manager
+1 (406) 370-6226
Philip.Buck@Trulieve.com

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/trulieve-cannabis-corp-announces-insider-share-purchases-by-executive-leadership-and-board-members-302313784.html

SOURCE Trulieve Cannabis Corp.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2024/22/c2393.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve to Open Florida Medical Cannabis Dispensaries in Dania Beach and Spring Hill

Grand opening celebrations at both new locations Friday, November 22 nd

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of new medical cannabis dispensaries in Dania Beach and Spring Hill, Florida .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Cronos Group Reports 2024 Third Quarter Results

Net revenue in Q3 2024 increased by 38% year-over-year to   $34.3 million

Spinach ® Becomes the Number One Cannabis Brand in Canada 1

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Cann Group Limited

AGM Presentation

In advance of this morning’s Annual General Meeting of shareholders to be held at 10:00am, and in accordance with ASX Listing Rule 3.13.3, Cann Group Limited (CAN:ASX) is pleased to provide a copy of the presentation that will be made to shareholders at the AGM.

Keep reading...Show less

Latest Press Releases

Related News

×